Cross-reactive Bundibugyo antibody responses after licensed Ebola vaccines
Edouard Lhomme, Aurélie Wiedemann, Ahidjo Ayouba, Safaa Ben-Farhat, Guillaume Thaurignac, Céline Roy, Abdoul Habib Beavogui, Seydou Doumbia, Mark Kieh, Bailah Leigh, Samba Sow, Stephen A Migueles, Deborah Watson-Jones, Yazdan Yazdanpanah, View ORCID ProfileRodolphe Thiébaut, Martine Peeters, Laura Richert, Yves Levy PREVAC study Team
doi: https://doi.org/10.64898/2026.05.27.26354223
Edouard Lhomme
1Univ. Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC 1401, Euclid/F-CRIN clinical trials platform and U1219 BPH, Inria, Sistm, F-33000 Bordeaux, France
M.D., Ph.D.,Aurélie Wiedemann
2French Institute for Health and Medical Research (INSERM), 75013 Paris, France
3Vaccine Research Institute, Univ. Paris Est Créteil, Henri Mondor Hospital, Créteil, France
Ph.D.,Ahidjo Ayouba
4Recherche Translationnelle Appliquée au VIH et aux Maladies Infectieuses, University of Montpellier, Institut de Recherche pour le Développement, INSERM, 34090, Montpellier, France
Ph.D.,Safaa Ben-Farhat
5Univ. Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC 1401, Euclid/F-CRIN clinical trials platform, F-33000 Bordeaux, France
6Univ. Bordeaux, INSERM, MART, UMS 54, F-33000 Bordeaux, France
M.Eng.,Guillaume Thaurignac
4Recherche Translationnelle Appliquée au VIH et aux Maladies Infectieuses, University of Montpellier, Institut de Recherche pour le Développement, INSERM, 34090, Montpellier, France
MSc,Céline Roy
5Univ. Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC 1401, Euclid/F-CRIN clinical trials platform, F-33000 Bordeaux, France
6Univ. Bordeaux, INSERM, MART, UMS 54, F-33000 Bordeaux, France
Ph.D,Abdoul Habib Beavogui
7Centre National de Formation et de Recherche en Santé Rurale de Maferinyah, Maferinyah, Guinea
M.D.,Seydou Doumbia
8University Clinical Research Center (UCRC), University of Sciences, Techniques and Technologies of Bamako (USTTB), Bamako, Mali
M.D., Ph.D.,Mark Kieh
9Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia
M.D., M.S.M.H.C.,Bailah Leigh
10College of Medicine and Allied Health Sciences (COMAHS), University of Sierra Leone, Freetown, Sierra Leone
M.D.,Samba Sow
11Center for Vaccine Development and Global Health, University of Maryland School of Medicine, 685 West Baltimore Street Baltimore, MD 21201-1509, USA
M.D,Stephen A Migueles
12National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA or under contract/subcontract to NIAID
MD,Deborah Watson-Jones
13London School of Hygiene & Tropical Medicine, London, UK
M.D., Ph.D,Yazdan Yazdanpanah
14ANRS Emerging Infectious Diseases, Paris, France
15AP-HP, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales, Paris F-75018, France
M.D., Ph.D,Rodolphe Thiébaut
1Univ. Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC 1401, Euclid/F-CRIN clinical trials platform and U1219 BPH, Inria, Sistm, F-33000 Bordeaux, France
M.D., PhD.,Martine Peeters
4Recherche Translationnelle Appliquée au VIH et aux Maladies Infectieuses, University of Montpellier, Institut de Recherche pour le Développement, INSERM, 34090, Montpellier, France
Ph.D.,Laura Richert
1Univ. Bordeaux, INSERM, Institut Bergonié, CHU de Bordeaux, CIC 1401, Euclid/F-CRIN clinical trials platform and U1219 BPH, Inria, Sistm, F-33000 Bordeaux, France
M.D.,Yves Levy
2French Institute for Health and Medical Research (INSERM), 75013 Paris, France
3Vaccine Research Institute, Univ. Paris Est Créteil, Henri Mondor Hospital, Créteil, France
M.D., Ph.D.
- Supplementary Appendix[supplements/354223_file02.docx]
Posted May 28, 2026.
Cross-reactive Bundibugyo antibody responses after licensed Ebola vaccines
Edouard Lhomme, Aurélie Wiedemann, Ahidjo Ayouba, Safaa Ben-Farhat, Guillaume Thaurignac, Céline Roy, Abdoul Habib Beavogui, Seydou Doumbia, Mark Kieh, Bailah Leigh, Samba Sow, Stephen A Migueles, Deborah Watson-Jones, Yazdan Yazdanpanah, Rodolphe Thiébaut, Martine Peeters, Laura Richert, Yves Levy
medRxiv 2026.05.27.26354223; doi: https://doi.org/10.64898/2026.05.27.26354223
Cross-reactive Bundibugyo antibody responses after licensed Ebola vaccines
Edouard Lhomme, Aurélie Wiedemann, Ahidjo Ayouba, Safaa Ben-Farhat, Guillaume Thaurignac, Céline Roy, Abdoul Habib Beavogui, Seydou Doumbia, Mark Kieh, Bailah Leigh, Samba Sow, Stephen A Migueles, Deborah Watson-Jones, Yazdan Yazdanpanah, Rodolphe Thiébaut, Martine Peeters, Laura Richert, Yves Levy
medRxiv 2026.05.27.26354223; doi: https://doi.org/10.64898/2026.05.27.26354223
Subject Area
Subject Areas
- Addiction Medicine (576)
- Allergy and Immunology (867)
- Anesthesia (306)
- Cardiovascular Medicine (4480)
- Dermatology (385)
- Emergency Medicine (614)
- Epidemiology (15276)
- Forensic Medicine (31)
- Gastroenterology (1133)
- Genetic and Genomic Medicine (6643)
- Geriatric Medicine (671)
- Health Economics (1006)
- Health Informatics (4602)
- Health Policy (1378)
- Hematology (544)
- HIV/AIDS (1275)
- Medical Education (626)
- Medical Ethics (147)
- Nephrology (674)
- Neurology (6692)
- Nursing (346)
- Nutrition (1006)
- Obstetrics and Gynecology (1152)
- Oncology (3369)
- Ophthalmology (988)
- Orthopedics (370)
- Otolaryngology (421)
- Pain Medicine (437)
- Palliative Medicine (131)
- Pathology (668)
- Pediatrics (1703)
- Primary Care Research (717)
- Public and Global Health (9284)
- Radiology and Imaging (2223)
- Respiratory Medicine (1201)
- Rheumatology (598)
- Sports Medicine (535)
- Surgery (720)
- Toxicology (100)
- Transplantation (290)
- Urology (266)




